Your email has been successfully added to our mailing list.

×
-0.00578034682080925 -0.00289017341040456 -0.0404624277456647 -0.0520231213872832 -0.0838728323699422 -0.0867052023121387 -0.142196531791908 -0.159768786127168
Stock impact report

Skyline Medical nearing completion of CytoBioscience merger; shares ahead 15% [Seeking Alpha]

SKYLINE MEDICAL INC COMMON (SKLN) 
Company Research Source: Seeking Alpha
Skyline Medical nearing completion of CytoBioscience merger; shares ahead 15%Skyline Medical (SKLN+15.5%)reports that it has submitted all the relevant paperwork to Nasdaq related to its planned merger with CytoBioscience. Additional financial and due diligence documentation to be provided by third parties will be filed in the coming weeks. The company expects the deal to be completed by the end of October.Now read:Cantel Medical Corporation 2017 Q4 - Results - Earnings Call Slides » Show less Read more
Impact Snapshot
Event Time:
SKLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for SKLN alerts
Opt-in for
SKLN alerts

from News Quantified
Opt-in for
SKLN alerts

from News Quantified